Cardiac Safety Expertise
Jay W. Mason, MD
Cardiac safety strategy from preclinical through Phase IV — serving pharmaceutical, biotech, and medical device companies and regulatory agencies worldwide.
Jay W. Mason, MD
Mason Cardiac Safety Consulting
Design and review of cardiac safety protocols for clinical trials
Rigorous statistical evaluation of electrocardiographic and cardiac safety data across all trial phases
Expert clinical interpretation of cardiac findings with regulatory-grade documentation
Comprehensive expert reports for regulatory submissions, litigation support, and advisory boards
Strategic preparation and direct participation in FDA advisory committee and pre-submission meetings
Evaluation and qualification of ECG equipment, core labs, and cardiac safety service providers
Mason Cardiac Safety Consulting
Cardiac safety expertise spanning preclinical through Phase IV — protocol design, ECG analysis, FDA support, and expert reporting. Trusted by pharmaceutical companies, biotech firms, and medical device manufacturers worldwide.